PRECISION BIOSCIENCES INC

DTIL NASDAQ
13.91
-0.91
-6.14%
盘后: 13.91 0 0.00% 17:04 07/19 EDT
开盘
14.80
昨收
14.82
最高
15.48
最低
13.69
成交量
8.84万
成交均量(3M)
19.37万
52周最高
19.00
52周最低
11.77
换手率
0.18%
市值
6.82亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供PRECISION BIOSCIENCES INC DTIL股票价格,PRECISION BIOSCIENCES INC股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Precision BioSciences, Inc. is a genome editing company. The Company is engaged in providing genome engineering technology. The Company’s ARCUS genome editing technology enables the production of specific nucleases that can insert, remove and modify deoxyribonucleic acid (DNA) at any location in a genome. The Company is also engaged in developing genome editing-based product leads for human therapeutic, agricultural and biologics manufacturing applications. The Company’s four product candidates in its CAR T cell development pipeline are PBCAR0191, PBCAR20A, PBCAR269A and PBCAR371A. The Company’s ARCUS platform designed to treat human diseases and create healthy and sustainable food and agricultural solutions. It also developing product candidates in three areas to overcome the limitations of other genome editing technologies: allogeneic CAR T immunotherapy, in vivo gene correction, and food.
展开 >

最近浏览

名称
价格
涨跌幅